GlassScriptPhysician profile
Vratika Agarwal
NPI 1780965228
$5,773.20
in general payments reported to CMS, 2019-2025
10 companies · $604 in 2025
The $604 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2021: $1,391 · 2022: $1,411 · 2023: $2,075 · 2024: $68.35 · 2025: $604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,625 · Food and Beverage: $1,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,625.00 |
| Food and Beverage | $1,122.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,198.69 | 2021-2025 | Mitraclip, Portico |
| Medtronic, INC. | $1,318.67 | 2021-2025 | Corevalve Evolut R |
| Edwards Lifesciences Corporation | $428.22 | 2022-2025 | Sapien 3 Ultra Resilia, Pascal |
| Philips North America LLC | $380.03 | 2022 | |
| Chiesi USA, INC. | $207.91 | 2019 | |
| Heartflow, INC. | $118.41 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.76 | 2019-2023 | Lifevest |
| Boston Scientific Corporation | $33.04 | 2023 | |
| Alnylam Pharmaceuticals INC. | $31.74 | 2025 | Amvuttra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.73 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vratika Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.